References
Baumler E, Ehrlich P. Scientist for life. New York: Holmes B. Meyer; 1984.
Jordan VC. Scientific Survival Suggestions (Appendix 1). In: Jordan VC, editor. Estrogen action, selective estrogen receptor modulators and women’s health: progress and promise. London: Imperial College Press; 2013. p. 459–64.
Jordan VC. Selective estrogen receptor modulation: a personal perspective. Cancer Res. 2003;61:5683–7.
Maximov PY, McDaniel RE, Jordan VC. Tamoxifen: milestones in drug therapy. Basel: Springer; 2013.
Jordan VC. The SERM saga, something from nothing: American Cancer Society/SSO basic science lecture. Ann Surg Oncol. Epub 25 Mar 2019. https://doi.org/10.1245/s10434-019-07291-1.
Maximov PY, Lee TM, Jordan VC. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol. 2013;8:135–55.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
V. Craig Jordan has no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections is a brief invited commentary on the article “The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture”, Ann Surg Oncol. Epub 25 Mar 2019.
Rights and permissions
About this article
Cite this article
Jordan, V.C. ASO Author Reflections: An Optimal Biological Model for Successful Drug Discovery. Ann Surg Oncol 26, 1991–1992 (2019). https://doi.org/10.1245/s10434-019-07337-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07337-4